Order Article Reprints

Ueshima K, Nishida N, Hagiwara S, Aoki T, Minami T, Chishina H, Takita M, Minami Y, Ida H, Takenaka M, et al. Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study. Cancers. 2019; 11(7):952. https://doi.org/10.3390/cancers11070952

Ueshima, Kazuomi, Naoshi Nishida, Satoru Hagiwara, Tomoko Aoki, Tomohiro Minami, Hirokazu Chishina, Masahiro Takita, Yasunori Minami, Hiroshi Ida, Mamoru Takenaka, and et al. 2019. "Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study" Cancers 11, no. 7: 952. https://doi.org/10.3390/cancers11070952

Ueshima, K., Nishida, N., Hagiwara, S., Aoki, T., Minami, T., Chishina, H., Takita, M., Minami, Y., Ida, H., Takenaka, M., Sakurai, T., Watanabe, T., Morita, M., Ogawa, C., Hiraoka, A., Johnson, P., & Kudo, M. (2019). Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study. Cancers, 11(7), 952. https://doi.org/10.3390/cancers11070952